Studies on tissue and cellular distribution of indoleamine 2,3-dioxygenase 2: The absence of IDO1 upregulates IDO2 expression in the epididymis

Journal of Histochemistry and Cytochemistry

Volumn 60, Issue 11, 2012, Pages 854-860

  Fukunaga, Masakazu ^a   Yamamoto, Yasuko ^a   Kawasoe, Misaki ^a   Arioka, Yuko ^a   Murakami, Yuki ^a   Hoshi, Masato ^b   Saito, Kuniaki ^a  

^a KYOTO UNIVERSITY   (Japan)

^b SUZUKA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

Author keywords

Epididymis; Indoleamine 2,3 dioxygenase 1; Indoleamine 2,3 dioxygenase 2

Indexed keywords

INDOLEAMINE 2,3 DIOXYGENASE; INDOLEAMINE 2,3 DIOXYGENASE 1; INDOLEAMINE 2,3 DIOXYGENASE 2; MESSENGER RNA; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; BILE DUCT; BRAIN CORTEX; BRAIN NERVE CELL; CELLULAR DISTRIBUTION; COLON; CONTROLLED STUDY; EPIDIDYMIS; GENE EXPRESSION; GENE TARGETING; IMMUNOHISTOCHEMISTRY; KIDNEY; KIDNEY COLLECTING TUBULE; KIDNEY PROXIMAL TUBULE; LIVER; LIVER CELL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PURKINJE CELL; SPERMATOZOON MATURATION; TISSUE DISTRIBUTION; TRYPTOPHAN METABOLISM; UPREGULATION; ANIMAL; C57BL MOUSE; GENE DELETION; GENETICS; METABOLISM;

MUS;

ANIMALS; CEREBRAL CORTEX; COLON; EPIDIDYMIS; GENE DELETION; GENE EXPRESSION; INDOLEAMINE-PYRROLE 2,3,-DIOXYGENASE; KIDNEY; LIVER; MALE; MICE; MICE, INBRED C57BL; RNA, MESSENGER; UP-REGULATION;

EID: 84872015298     PISSN: 00221554     EISSN: None     Source Type: Journal    
DOI: 10.1369/0022155412458926     Document Type: Article

References (19)

1. Austin CJD, Mailu BM, Maghzal GJ, Sanchez-Perez A, Rahlfs S, Zocher K, Yuasa HJ, Arthur JW, Becker K, Stocker R. et al. 2010. Biochemical characteristics and inhibitor selectivity of mouse indoleamine 2,3-dioxygenase-2. Amino Acids. 39(2):565-578.
2. Ball HJ, Sanchez-Perez A, Weiser S, Austin CJD, Astelbauer F, Miu J, McQuillan JA, Stocker R, Jermiin LS, Hunt NH. 2007. Characterization of an indoleamine 2,3-dioxygenase-like protein found in humans and mice. Gene. 396(1):203-213.
3. Ball HJ, Yuasa HJ, Austin CJD, Weiser S, Hunt NH. 2009. Indoleamine 2,3-dioxygenase-2: a new enzyme in the kynurenine pathway. Int J Biochem Cell Biol. 41(3):467-471.
4. Britan A, Maffre V, Tone S, Drevet JR. 2006. Quantitative and spatial differences in the expression of tryptophan-metabolizing enzymes in mouse epididymis. Cell Tissue Res. 324(2):301-310.
5. Dai X, Zhu BT. 2010. Indoleamine 2,3-dioxygenase tissue distribution and cellular localization in mice: implications for its biological functions. J Histochem Cytochem. 58(1):17-28.
6. Frumento G, Rotondo R, Tonetti M, Damonte G, Benatti U, Ferrara GB. 2002. Tryptophan-derived catabolites are responsible for inhibition of T and natural killer cell proliferation induced by indoleamine 2,3-dioxygenase. J Exp Med. 196(4):459-468.
7. Grohmann U, Orabona C, Fallarino F, Vacca C, Calcinaro F, Falorni A, Candeloro P, Belladonna ML, Bianchi R, Fioretti MC, et al. 2002. CTLA-4-Ig regulates tryptophan catabolism in vivo. Nat Immunol. 3(11):1097-1101.
8. Gupta NK, Thaker AI, Kanuri N, Riehl TE, Rowley CW, Stenson WF, Ciorba MA. 2011. Serum analysis of tryptophan catabolism pathway: correlation with Crohn's disease activity. Inflamm Bowel Dis. 18(7):1214-1220.
9. Hoshi M, Saito K, Hara A, Taguchi A, Ohtaki H, Tanaka R, Fujigaki H, Osawa Y, Takemura M, Matsunami H, et al. 2010. The absence of IDO upregulates type I IFN production, resulting in suppression of viral replication in the retrovirus-infected mouse. J Immunol. 185(6):3305-3312.
10. Itoh M, Terayama H, Naito M, Ogawa Y, Tainosho S. 2005. Tissue microcircumstances for leukocytic infiltration into the testis and epididymis in mice. J Reprod Immunol. 67:57-67.
11. Jrad-Lamine A, Henry-Berger J, Gourbeyre P, Damon-Soubeyrand C, Lenoir A, Combaret L, Saez F, Kocer A, Tone S, Fuchs D, et al. 2011. Deficient tryptophan catabolism along the kynurenine pathway reveals that the epididymis is in a unique tolerogenic state. J. Biol. Chem. 286(10):8030-8042.
12. Loeb S, Koenigsrainer A, Zieker D, Bruecher BLDM, Rammensee H-G, Opelz G, Terness P. 2009. IDO1 and IDO2 are expressed in human tumors: levo-but not dextro-1-methyl tryptophan inhibits tryptophan catabolism. Cancer Immunol Immunother. 58(1):153-157.
13. Metz R, DuHadaway JB, Kamasani U, Laury-Kleintop L, Muller AJ, Prendergast GC. 2007. Novel tryptophan catabolic enzyme IDO2 is the preferred biochemical target of the antitumor indoleamine 2,3-dioxygenase inhibitory compound D-1-methyl-tryptophan. Cancer Res. 67(15):7082-7087.
14. Robaire B, Hermo L. 1988. Efferent ducts, epididymis, and vas deferens: structure, functions, and their regulation. In: Knobil E, Neill J, editors. The physiology of reproduction. New York: Raven. p. 999-1080.
15. Turner TT. 1991. Spermatozoa are exposed to a complex microenvironment as they traverse the epididymis. Ann N Y Acad Sci. 637:364-383.
16. Turner TT. 1995. On the epididymis and its role in the development of the fertile ejaculate. J. Androl. 16(4):292-298.
17. Uyttenhove C, Pilotte L, Theate I, Stroobant V, Colau D, Parmentier N, Boon T, Van den Eynde BJ. 2003. Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase. Nat Med. 9(10):1269-1274.
18. Yoshida R, Nukiwa T, Watanabe Y, Fujiwara M, Hirata F, Hayaishi O. 1980. Regulation of indoleamine 2,3-dioxygenase activity in the small-intestine and the epididymis of mice. Arch Biochem Biophys. 203(1):343-351.
19. Yuasa HJ, Hasegawa T, Nakamura T, Suzuki T. 2007. Bacterial expression and characterization of molluscan IDO-like myoglobin. Comp Biochem Physiol B Biochem Mol Biol. 146(4):461-469.